logo
Share SHARE
FONT-SIZE Plus   Neg

Anthera Pharma Prices $40 Mln Stock Offering

Anthera Pharmaceuticals, Inc. (ANTH) said Friday that it has priced an underwritten public offering of about 60.6 million shares of its common stock, offered at a price of $0.66 per share.

The company estimates that the gross proceeds from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Anthera, will be $40.0 million.

In addition, the company has granted the underwriters a 30-day option to purchase up to an additional about 9.1 million shares of common stock.

The offering is expected to close on or about January 30.

The company plans to use the net proceeds from the offering for general corporate purposes.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Jeff Bezos is now the world's second richest person. The founder and CEO of e-commerce giant Amazon.com Inc. has leapfrogged Berkshire Hathaway CEO Warren Buffett and Inditex fashion group founder Amancio Ortega to claim the second spot. In the annual letter to shareholders of hedge fund Pershing Square Capital Management L.P, CEO Bill Ackman admitted that the investment in Valeant Pharmaceuticals was a huge mistake. Valeant stock was down 19.2 percent in 2016 and tarnished the image of the hedge fund. A video posted by an outraged mother of her 13-year-old special needs son getting a thorough pat-down by a Transportation Security Administration officer at Dallas/Fort Worth International Airport has gone viral. The Texas woman, Jennifer Williamson, posted the two-minute video to Facebook on Sunday, showing her son who suffers from sensory processing disorder or SPD getting a thorough pat-down.
comments powered by Disqus
Follow RTT